Phencyclidine *(PCP) and its congeners, including:
eticyclidine (N-ethyl-l-phenylcyclohexylamine *(PCE));
rolycyclidine (1-(1-phenylcyclohexyl) pyrrolidine *(PHP or PCPY)); and
tenocyclidine (1-[1-(2-thienyl) cyclohexyl] piperidine *(TCP).
Phenmetrazine.
Psilocin (4-hydroxy-NN-dimethyltryptamine).
Psilocybine (4-phosphoryloxy-NN-dimethyltryptamine).
Pyrovalerone (4’-methyl-2-(1-pyrrolidinyl) valerophenone).
Tenamfetamine (methylenedioxyamphetamine *(MDA)) and its analogues:
(±)-N-ethyl-a-methyl-3,4 (methylenedioxy) phenethylamine *(N-ethyl MDA),
(±)-N-[a-methyl-3,4-(methylenedioxy) phenethyl] hydroxylamine *(N-hydroxy MDA);
Tetrahydrocannabinol and their alkyl homologues, except:
(a)
when separately specified in the Schedules;
(b)
dronabinol ((-)-transdelta-9-tetrahydrocannabinol), when intended for therapeutic
purposes. (S6);
(c)
in hemp seed oil, containing 10mg/kg or less of tetrahydrocannabinols, when labelled
“Not to be taken” (Not for internal human use – alternatively); or
(d)
in products for purposes other than internal human use containing 10mg/kg or less of
tetrahydrocannabinols.
[“Hemp seed oil” means the oil obtained by cold expression from the ripened fruits
(seeds) of Cannabis sativa.]
(±)-3, 4, 5-trimethoxy-a-methylphenethylamine *(TMA).
Schedule 8
[Schedule 8 added by s. 36 of Act No. 65 of 1974, substituted by Government Notices No. R.420 of 7
March, 1975, No. R.2244 of 28 November, 1975, No. R.575 of 2 April, 1976 and No. R.2082 of 5
November, 1976, amended by Government Notices No. R.437 of 1 April, 1977, No. R.1567 of 12
August, 1977, No. R.1674 of 18 August, 1978 (as amended by Government Notice No. 2410 of 8
December, 1978), No. R.1926 of 31 August, 1979, No. R.658 of 27 March, 1981, No. R.2416 of 12
November, 1982 and No. R.1289 of 14 June, 1985, substituted by Government Notice No. 225 of 17
February, 1989, amended by Government Notices No. R.1133 of 2 June, 1989, No. R.2841 of 7
December, 1990 and No. R.775 of 7 May, 1993, repealed, and subsequently re-inserted (after
amendment), by s. 21 of Act No. 94 of 1991, amended by Government Notice No. R.1556 of 16
September, 1994, by Government Notice No. R.1203 of 15 October, 1999 and by Government Notice
No. R.1077 of 3 November, 2000, repealed by s. 27 of Act No. 90 of 1997 and inserted by Government
Notice No. R.509 in Government Gazette 24727 of 10 April, 2003 with effect from 2 May, 2003.]
Wording of Sections
All substances referred to in this Schedule include the following (unless expressly excluded or unless
listed in another Schedule):
(a)
the isomers of such substances, where the existence of such isomers is possible
within the chemical designation;
(b)
the esters and ethers of such substances and of the isomers referred to in (a), as well
as the isomers of such esters and ethers, where the existence of such esters, ethers and isomers is
possible;
(c)
the salts of such substances and of the isomers referred to in (a), as well as the salts
of the esters, ethers and isomers referred to in (b), where the existence of such salts is possible;
(d)
the isomers of any of the salts referred to in (c), where the existence of such isomers
is possible;
(e)
all preparations and mixtures of any of the above.
Amphetamine and its salts; preparations thereof. (S7)
Dexamphetamine and its salts; preparations thereof. (S7)
Nabilone. (S7)
Schedule 9
[Schedule 9 added by s. 36 of Act No. 65 of 1974, substituted by Government Notices No. R.420 of 7
March, 1975, No. R.2244 of 28 November, 1975, No. R.575 of 2 April, 1976 and No. R.2082 of 5
November, 1976, amended by Government Notices No. R.437 of 1 April, 1977, No. R.2416 of 12
November, 1982 and No. R.1289 of 14 June, 1985, substituted by Government Notice No. 225 of 17
February, 1989, amended by Government Notice No. R.775 of 7 May, 1993, repealed, and
subsequently re-inserted (after amendment), by s. 21 of Act No. 94 of 1991 and repealed by s. 27 of Act
No. 90 of 1997.]
Wording of Sections